Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Pediatric Cancer 2016 NINDS 4R01NS073870-06 Defining the role of BRAF in glioma initiation and maintenance HOLMEN, SHERI UNIVERSITY OF UTAH UT $325,938
Pediatric Cancer 2016 NINDS 4U01NS082328-03 Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma ABOODY, KAREN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1,238,896
Pediatric Cancer 2016 NCI 1K22CA197074-01 Exosomic microRNAs and drug resistance in AML tumor microenvironment CHALLAGUNDLA, KISHORE UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $154,958
Pediatric Cancer 2016 NCI 4R01CA072669-19 Cytotoxic-T-Lymphocyte (CTL) Therapy of AML BLAZAR, BRUCE UNIVERSITY OF MINNESOTA MN $294,076
Pediatric Cancer 2016 NCI 5R01CA132640-15 Role of heat shock factors (Hsfs) in tumorigenesis MIVECHI, NAHID GEORGIA REGENTS UNIVERSITY GA $270,000
Pediatric Cancer 2016 NCI 4U24CA055727-22 Childhood Cancer Survivor Study ARMSTRONG, GREGORY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $4,172,004
Pediatric Cancer 2016 NCI 5R01CA190964-02 Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $544,106
Pediatric Cancer 2016 NHLBI 5K08HL118367-03 ELUCIDATING THE ROLE OF KRUPPEL LIKE FACTOR 7 IN T CELL DEVELOPMENT SCHUETTPELZ, LAURA WASHINGTON UNIVERSITY MO $26,438
Pediatric Cancer 2016 NCI 4P30CA006516-51 6056 Neuro-Oncology MARTUZA, ROBERT MASSACHUSETTS GENERAL HOSPITAL MA $93,279
Pediatric Cancer 2016 NCI 5R01CA090668-13 FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia SMALL, DONALD JOHNS HOPKINS UNIVERSITY MD $291,600
Pediatric Cancer 2016 NHLBI 5F32HL124948-02 Characterization of Calmodulin and CHK2 inhibitors for the treatment of Diamond B MACARI, ELIZABETH CHILDREN'S HOSPITAL CORPORATION MA $58,002
Pediatric Cancer 2016 NCI 5R03CA182063-03 Persistent SIX2 expression as a first hit mechanism in Wilms tumorigenesis LOVVORN, HAROLD VANDERBILT UNIVERSITY MEDICAL CENTER TN $79,000
Pediatric Cancer 2016 NCI 5R21CA191544-02 CendR peptide-mediated enhancement of systemic oncolytic herpes virotherapy CRIPE, TIMOTHY RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $195,098
Pediatric Cancer 2016 NHLBI 4R01HL111103-05 Identification and characterization of genes in del(5q) myelodysplastic syndrome STARCZYNOWSKI, DANIEL CINCINNATI CHILDRENS HOSP MED CTR OH $382,500
Pediatric Cancer 2016 NCI 7R21CA192003-02 Deciphering the pathogenesis of pediatric high-grade gliomas LI, GUO-MIN UNIVERSITY OF SOUTHERN CALIFORNIA CA $194,290
Pediatric Cancer 2016 NCI 4R01CA158006-05 Ikaros-based epigenetic regulation of T cell leukemogenesis GEORGOPOULOS, KATIA MASSACHUSETTS GENERAL HOSPITAL MA $342,218
Pediatric Cancer 2016 NCI 4R01CA157838-05 Longitudinal Cardiotoxicity in Adult Survivors Childhood Cancer ARMSTRONG, GREGORY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $536,801
Pediatric Cancer 2016 NCI 5R01CA182528-04 Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $336,114
Pediatric Cancer 2016 NICHD 4R01HD062484-06 Pharmacogenetic Determinants of Vincristine Toxicity and Response RENBARGER, JAMIE INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $614,577
Pediatric Cancer 2016 NCI 4R01CA118332-09 Parent-Child Communication About Cancer COMPAS, BRUCE VANDERBILT UNIVERSITY TN $393,884
Pediatric Cancer 2016 NCI 4R01CA167708-04 Targeting AML with PI3K/AKT inhibitors and BH3-mimetics GRANT, STEVEN VIRGINIA COMMONWEALTH UNIVERSITY VA $284,794
Pediatric Cancer 2016 NCI 5R01CA190617-02 Itraconazole Analogues to Treat Medulloblastoma HADDEN, MATTHEW UNIVERSITY OF CONNECTICUT STORRS CT $367,973
Pediatric Cancer 2016 NCI 5P30CA008748-50 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $206,350
Pediatric Cancer 2016 NCI 5R01CA191077-02 Assay Development for NSD1 Methyltransferase Inhibitor Discovery NAPPER, ANDREW ALFRED I. DU PONT HOSP FOR CHILDREN DE $312,244
Pediatric Cancer 2016 NCI 5R01CA185301-02 Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention CALIGIURI, MICHAEL OHIO STATE UNIVERSITY OH $352,275
Pediatric Cancer 2016 NCI 5R01CA178380-03 Leukotriene-Induced Nestin Expression Promotes Medulloblastoma Tumorigenesis YANG, ZENG-JIE RESEARCH INST OF FOX CHASE CAN CTR PA $370,388
Pediatric Cancer 2016 NCI 5K08CA181340-03 Targeting Chromatin Modifications in Leukemia with Trisomy 21 LANE, ANDREW DANA-FARBER CANCER INST MA $155,991
Pediatric Cancer 2016 NCI 5F30CA183507-03 Cytotoxicity of MLN4924 in Acute Myeloid Leukemia KNORR, KATHERINE MAYO CLINIC ROCHESTER MN $42,276
Pediatric Cancer 2016 NCI 5R01CA142928-07 Targeting the Kinome in Neurofibromatosis type 1 CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR PA $423,938
Pediatric Cancer 2016 NCI 5R21CA185036-02 Identification and Targeting Therapy Resistant Osteosarcoma MAKI, CARL RUSH UNIVERSITY MEDICAL CENTER IL $167,987
Pediatric Cancer 2016 NCI 4R01CA173636-04 Role of TET2 mutations in malignant transformation and acute myeloid leukemia LEVINE, ROSS SLOAN-KETTERING INST CAN RESEARCH NY $639,626
Pediatric Cancer 2016 NHLBI 5R01HL117976-03 Epithelial mechanisms of inducible resistance to AML-associated pneumonia EVANS, SCOTT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $400,000
Pediatric Cancer 2016 NIAID 4R01AI018757-34 Host Immunity to EBV Infection in Vitro and in Vivo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $412,500
Pediatric Cancer 2016 NCI 5K07CA174728-03 A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors DEVINE, KATIE RBHS -CANCER INSTITUTE OF NEW JERSEY NJ $164,851
Pediatric Cancer 2016 NINDS 5R21NS092001-02 In Vivo Analysis of TrkB Signaling During Sympathetic Nervous System Development and Neuroblastoma Pathogenesis KULESA, PAUL STOWERS INSTITUTE FOR MEDICAL RESEARCH MO $206,250
Pediatric Cancer 2016 NCI 5R01CA137060-08 PRE-B CELL RECEPTOR SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA MUSCHEN, MARKUS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $356,625
Pediatric Cancer 2016 NCI 4R37CA072614-20 Translational Investigation of KRas & NF1 in Myeloid Leukemia SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $304,773
Pediatric Cancer 2016 NCI 4R01CA172398-04 The role of ETV6 in T-cell acute lymphoblastic leukemia FERRANDO, ADOLFO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Pediatric Cancer 2016 NCI 4R01CA160433-05 The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission) ARMANIOS, MARY JOHNS HOPKINS UNIVERSITY MD $336,150
Pediatric Cancer 2016 NCI 5R00CA178207-04 Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma BENAVENTE ARIAS, CLAUDIA UNIVERSITY OF CALIFORNIA-IRVINE CA $246,582
Pediatric Cancer 2016 NCI 5F30CA183269-03 Exosomal MicroRNA as a Driver of Immune Evasion in AML HORNICK, NOAH OREGON HEALTH & SCIENCE UNIVERSITY OR $42,732
Pediatric Cancer 2016 NCI 2P30CA016520-40 7999 Clinical Protocol and Data Management (Core 012) VOGL, DAN UNIVERSITY OF PENNSYLVANIA PA $1,045,017
Pediatric Cancer 2016 NCI 2P30CA016520-40 8007 Hematologic Malignancies Research Program STADTMAUER, EDWARD UNIVERSITY OF PENNSYLVANIA PA $72,887
Pediatric Cancer 2016 NCI 2P30CA016520-40 8009 Pediatric Oncology Research Program BRODEUR, GARRETT UNIVERSITY OF PENNSYLVANIA PA $70,898
Pediatric Cancer 2016 NCI 5R33CA191143-02 Single cell growth assay for residual cells in acute lymphoblastic leukemia MANALIS, SCOTT MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $366,536
Pediatric Cancer 2016 NCI 2P30CA014089-41 8290 Tumor Microenvironment Research Program (Project-003) DECLERCK, YVES UNIVERSITY OF SOUTHERN CALIFORNIA CA $35,512
Pediatric Cancer 2016 NCI 2P30CA062203-19 8736 Clinical Protocol and Data Management (CPDM) O'BRIEN, SUSAN UNIVERSITY OF CALIFORNIA-IRVINE CA $233,836
Pediatric Cancer 2016 NCI 2P30CA016058-40 5094 Clinical Protocol and Data Management (Core 017) DEVINE, STEVEN OHIO STATE UNIVERSITY OH $376,607
Pediatric Cancer 2016 NCI 5F30CA183276-03 Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis PEDERSEN, ELISABETH UNIVERSITY OF MICHIGAN MI $34,015
Pediatric Cancer 2016 NCI 5F31CA183529-03 Targeting aerobic glycolysis in T-ALL KISHTON, RIGEL DUKE UNIVERSITY NC $17,159
Pediatric Cancer 2016 NCI 4P30CA046934-28 8118 STAFF INVESTIGATORS BUNN, PAUL UNIVERSITY OF COLORADO DENVER CO $56,573
Pediatric Cancer 2016 NCI 4P30CA046934-28 8122 PREVENTION-CONTROL MARCUS, AL AMC CANCER RESEARCH CENTER CO $36,905
Pediatric Cancer 2016 NCI 4R01CA172268-04 The role of inhibitory receptors in leukemia development ZHANG, CHENGCHENG UT SOUTHWESTERN MEDICAL CENTER TX $329,925
Pediatric Cancer 2016 NCI 4R01CA172387-04 Polysomy 21 in Acute Lymphoblastic Leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $352,946
Pediatric Cancer 2016 NHLBI 1R01HL130034-01 The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML FRIEDMAN, ALAN JOHNS HOPKINS UNIVERSITY MD $405,000
Pediatric Cancer 2016 NIGMS 2SC1GM093999-07 Molecular Analysis of RECQ1 Functions in Genome Maintenance SHARMA, SUDHA HOWARD UNIVERSITY DC $327,000
Pediatric Cancer 2016 NIAID 4U01AI104342-04 Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children ESQUIVEL, CARLOS STANFORD UNIVERSITY CA $1,363,549
Pediatric Cancer 2016 NCI 4P01CA094237-14 7520 VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,517
Pediatric Cancer 2016 NCI 4P01CA094237-14 7530 CHIMERIC T CELLS TARGETING NEUROBLASTOMA HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,508
Pediatric Cancer 2016 NHLBI 5R01HL117737-17 Microchimerism as AlloImmunity NELSON, J. FRED HUTCHINSON CANCER RESEARCH CENTER WA $477,844
Pediatric Cancer 2016 NHLBI 1R01HL131444-01 The role of EVI1-induced hypermethylation in leukemogenesis. QIAN, ZHIJIAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,708
Pediatric Cancer 2016 NICHD 1R01HD086195-01 Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors LI, YUANPEI UNIVERSITY OF CALIFORNIA AT DAVIS CA $311,049
Pediatric Cancer 2016 NCI 1R01CA201184-01 Biologic and Therapeutic Significance of miR-155 in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $574,050
Pediatric Cancer 2016 NCI 1K07CA200668-01 Patient Preferences and Adherence in Adolescents and Young Adults with Cancer MCGRADY, MEGHAN CINCINNATI CHILDRENS HOSP MED CTR OH $144,855
Pediatric Cancer 2016 NINDS 5R01NS088219-02 Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis GERSHON, TIMOTHY UNIV OF NORTH CAROLINA CHAPEL HILL NC $327,837
Pediatric Cancer 2016 NCI 5R01CA190843-02 A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia SOHN, LYDIA UNIVERSITY OF CALIFORNIA BERKELEY CA $311,458
Pediatric Cancer 2016 NCI 1K22CA201103-01 Targeting nutrient-sensing pathways in cancer LAZARUS, MICHAEL ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $190,640
Pediatric Cancer 2016 NCI 4R01CA164024-04 Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML HORTON, TERZAH BAYLOR COLLEGE OF MEDICINE TX $309,159
Pediatric Cancer 2016 NCI 5R21CA185799-02 Exploring the oncogenic potential of human APOBEC3 cytosine deaminases WEITZMAN, MATTHEW CHILDREN'S HOSP OF PHILADELPHIA PA $219,240
Pediatric Cancer 2016 NCI 5R01CA192924-02 CSF2 receptor mediated actions in t(8;21) leukemia ZHANG, DONG-ER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $344,868
Pediatric Cancer 2016 NCI 1R21CA187548-01A1 Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma BARANOWSKA-KORTYLEWICZ, JANINA UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $196,403
Pediatric Cancer 2016 NCI 5R21CA183623-02 Pediatric Cancer Salvia Biorepository GRAHAM, DAVID JOHNS HOPKINS UNIVERSITY MD $251,676
Pediatric Cancer 2016 NCI 5R01CA194057-02 Metabolic pathways in leukemia SCHUETZ, JOHN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $409,749
Pediatric Cancer 2016 NCI 5R01CA183874-02 Mechanism of tumor promotion by the H3K9 histone demethylase KDM3A in Ewing Sarcoma. JEDLICKA, PAUL UNIVERSITY OF COLORADO DENVER CO $355,706
Pediatric Cancer 2016 NCI 1R03CA201540-01 Cognitive and Psychosocial Functioning of Children Treated for Retinoblastoma WILLARD, VICTORIA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $89,312
Pediatric Cancer 2016 NCI 5F30CA186466-02 Role of GSK3beta Subcellular Localization in AML Stemness IGNATZ-HOOVER, JAMES CASE WESTERN RESERVE UNIVERSITY OH $28,572
Pediatric Cancer 2016 NCI 5F31CA192558-02 Epigenetic Regulation of Neuroblast Differentiation GAVIGLIO, ANGELA DUKE UNIVERSITY NC $26,208
Pediatric Cancer 2016 NIDCR 5K99DE023826-02 Hedgehog Pathway Activity and Targeting in KCOT AMM, HOPE UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $123,378
Pediatric Cancer 2016 NIDDK 5R01DK105014-02 Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes HUANG, GANG CINCINNATI CHILDRENS HOSP MED CTR OH $351,000
Pediatric Cancer 2016 NCI 4R01CA132685-09 Molecular Mechanisms Regulating the Retinoblastoma Protein Family RUBIN, SETH UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $290,171
Pediatric Cancer 2016 NCI 5R01CA193235-02 Metabolic Regulation in Leukemia-Initatiating Cells NAKADA, DAISUKE BAYLOR COLLEGE OF MEDICINE TX $462,191
Pediatric Cancer 2016 NIGMS 4R01GM103999-04 Mouse Models of Functional Insertion Polymorphisms BURNS, KATHLEEN JOHNS HOPKINS UNIVERSITY MD $307,800
Pediatric Cancer 2016 NICHD 5R01HD079568-02 MICROBLEEDS AS A MARKER OF RADIATION-INDUCED BRAIN INJURY IN PEDIATRIC PATIENTS LUPO, JANINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $493,296
Pediatric Cancer 2016 NCI 2R01CA080728-16A1 Dissection of eIF4E dependent mRNA export BORDEN, KATHERINE UNIVERSITY OF MONTREAL CANADA $210,799
Pediatric Cancer 2016 NCI 4R01CA172392-04 Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion CASTELLINO, ROBERT EMORY UNIVERSITY GA $323,700
Pediatric Cancer 2016 NCI 5R01CA174683-03 Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia BHATIA, SMITA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $620,968
Pediatric Cancer 2016 NCI 1R03CA201953-01 Adolescent tanning and social media MORENO, MEGAN SEATTLE CHILDREN'S HOSPITAL WA $75,000
Pediatric Cancer 2016 NCI 1R21CA194829-01A1 Metabolic regulation of T-ALL cellular proliferation and lifespan RATHMELL, JEFFREY VANDERBILT UNIVERSITY TN $18,375
Pediatric Cancer 2016 NCI 4R01CA160593-04 Survival Bump Hunting for Finding Informative Subgroups in High Dimensional Data. RAO, J UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $261,828
Pediatric Cancer 2016 NCI 5R01CA185687-02 Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging SMITH-BINDMAN, REBECCA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $2,196,358
Pediatric Cancer 2016 NCI 1R21CA202210-01 Symptom progress and adverse health outcomes in adult childhood cancer survivors HUANG, I-CHAN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $233,106
Pediatric Cancer 2016 NCI 4R01CA160872-05 Discovery and Optimization of AML Prognostic Biomarkers STIREWALT, DEREK FRED HUTCHINSON CANCER RESEARCH CENTER WA $458,821
Pediatric Cancer 2016 NCI 4R01CA160256-05 Temporal and Spatial Control of V(D)J Recombination DESIDERIO, STEPHEN JOHNS HOPKINS UNIVERSITY MD $336,150
Pediatric Cancer 2016 NCI 4R01CA172040-04 Microenvironment-Leukemia Communication Through Lectins HEISTERKAMP, NORA CHILDREN'S HOSPITAL OF LOS ANGELES CA $336,150
Pediatric Cancer 2016 NCI 5R01CA188520-02 Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy BHASKARA, SRIVIDYA UNIVERSITY OF UTAH UT $340,838
Pediatric Cancer 2016 NCI 1R21CA191818-01A1 Proton minibeams: Overcoming proton beams’ inability to spare superficial tissues KRISHNAN, SUNIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $235,488
Pediatric Cancer 2016 NCI 1R01CA195732-01A1 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $343,125
Pediatric Cancer 2016 NCI 1R21CA191989-01A1 Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $202,275
Pediatric Cancer 2016 NCI 5U10CA180899-03 Children's Oncology Group Statistics and Data Center DEVIDAS, MEENAKSHI UNIVERSITY OF FLORIDA FL $8,167,603
Pediatric Cancer 2016 NCI 5P30CA021765-37 6700 Cancer Prevention & Control GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $586,947
Pediatric Cancer 2016 NCI 5P30CA021765-37 6701 Developmental Biology and Solid Tumor GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $984,904
Pediatric Cancer 2016 NCI 5P30CA021765-37 6702 Hematalogical Malignancies GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $693,252
Pediatric Cancer 2016 NCI 5P30CA021765-37 6703 Neurobiology and Brain Tumors GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $324,910
Pediatric Cancer 2016 NCI 5P30CA021765-37 6704 Shared Resource Group1: Genomics and Statistics GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $188,256
Pediatric Cancer 2016 NCI 5P30CA021765-37 6707 Data and Safety Monitoring/NIH Policy GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $152,691
Pediatric Cancer 2016 NCI 5P30CA021765-37 6708 Protocol Review and Monitoring System GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $254,438
Pediatric Cancer 2016 NCI 5P30CA021765-37 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $255,476
Pediatric Cancer 2016 NCI 5P30CA021765-37 6710 Senior Leadership GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $370,919
Pediatric Cancer 2016 NCI 5P30CA021765-37 6711 Planning and Evaluation GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $75,012
Pediatric Cancer 2016 NCI 5P30CA021765-37 6713 Administration GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $257,436
Pediatric Cancer 2016 NCI 5P30CA021765-37 6716 Transdisciplinary Collaboration and Coordination GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $318,644
Pediatric Cancer 2016 NCI 5R01CA169784-03 Genetic Dissection of Acute Myeloid Leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $355,993
Pediatric Cancer 2016 NCI 5R01CA129541-11 An investigation of Radial Glia as the source of Ependymoma Stem Cells GILBERTSON, RICHARD UNIVERSITY OF CAMBRIDGE UK $199,044
Pediatric Cancer 2016 NCI 5U10CA180884-03 COG NCTN Solid Malignancy Integrated Translational Science Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $400,000
Pediatric Cancer 2016 NCI 1R01CA187219-01A1 Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas POLLACK, IAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $357,496
Pediatric Cancer 2016 NCI 5R01CA166429-05 Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia STEIDL, ULRICH ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $384,342
Pediatric Cancer 2016 NCI 4R01CA174793-04 BET bromodomain inhibition as targeted therapy in acute myeloid leukemia VAKOC, CHRISTOPHER COLD SPRING HARBOR LABORATORY NY $557,762
Pediatric Cancer 2016 NCI 2R01CA142665-06 Glucocorticoids in Lymphoblastic Leukemia RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $485,955
Pediatric Cancer 2016 NCI 2R01CA142874-06A1 Targeting PML for Leukemia Therapy PANDOLFI, PIER PAOLO BETH ISRAEL DEACONESS MEDICAL CENTER MA $465,791
Pediatric Cancer 2016 NCI 1R01CA193677-01A1 Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma SCACHERI, PETER CASE WESTERN RESERVE UNIVERSITY OH $362,569
Pediatric Cancer 2016 NCI 1R01CA194058-01A1 Painted erythrocyte carriers for therapy of acute myeloid leukemia SIMBERG, DIMITRI UNIVERSITY OF COLORADO DENVER CO $352,151
Pediatric Cancer 2016 NICHD 1R01HD083930-01A1 Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation ZELINSKI, MARY OREGON HEALTH & SCIENCE UNIVERSITY OR $605,663
Pediatric Cancer 2016 NCI 5R01CA166559-05 Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors LANDIER, WENDY UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $674,412
Pediatric Cancer 2016 NICHD 5R21HD081319-02 Combination strategies to enhance therapy for Ph-like B-ALL FRUMAN, DAVID UNIVERSITY OF CALIFORNIA-IRVINE CA $201,951
Pediatric Cancer 2016 NCI 4R01CA166770-05 Characterization of a T cell dysfunctional state induced in mice with AML KLINE, JUSTIN UNIVERSITY OF CHICAGO IL $327,850
Pediatric Cancer 2016 NCI 5U10CA180866-03 Network Lead Academic Participating Site Grant from the Roswell Cancer Inst. LEVINE, ELLIS ROSWELL PARK CANCER INSTITUTE CORP NY $616,000
Pediatric Cancer 2016 NCI 5R21CA181417-02 Molecular determinants of PARP inhibitor sensitivity in 11q-deleted malignancy FRANCO, SONIA JOHNS HOPKINS UNIVERSITY MD $219,957
Pediatric Cancer 2016 OD 4K01OD010554-06 Loss of EBF1 Expression: A Novel Murine Model for Human B-ALL RAMIREZ, JULITA UNIVERSITY OF WASHINGTON WA $78,062
Pediatric Cancer 2016 NCI 5R01CA178454-04 The role and functional mechanism of TET1 in MLL-rearranged leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $327,850
Pediatric Cancer 2016 NCI 5R01CA180692-02 Role of LMO1 in Neuroblastoma Initiation and Maintenance MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $606,838
Pediatric Cancer 2016 NCI 5U10CA180886-03 COG NCTN Network Group Operations Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $21,084,883
Pediatric Cancer 2016 NCI 5R01CA195642-02 Triad1 regulates myelopoiesis and functions as a leukemia suppressor EKLUND, ELIZABETH NORTHWESTERN UNIVERSITY AT CHICAGO IL $353,419
Pediatric Cancer 2016 NHLBI 5K08HL127269-02 Bone Marrow Microenvironmental Expression of Cytochrome P450 Enzymes GHIAUR, GABRIEL JOHNS HOPKINS UNIVERSITY MD $171,720
Pediatric Cancer 2016 NCI 4R01CA163452-04 Novel lysine deacetylase 6 Hsp domain inhibitors against AML CHOU, CHUNG-JEN JAMES MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $310,213
Pediatric Cancer 2016 NCI 5R01CA193842-02 Characterizing MSI2 in leukemia KHARAS, MICHAEL SLOAN-KETTERING INST CAN RESEARCH NY $414,827
Pediatric Cancer 2016 NCI 4R01CA124709-09 The Genetic Basis of Neuroblastoma Tumorigenesis MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $614,290
Pediatric Cancer 2016 NINDS 5R01NS091219-02 Targeting Wee1 in Myc driven Medulloblasoma VIBHAKAR, RAJEEV UNIVERSITY OF COLORADO DENVER CO $255,118
Pediatric Cancer 2016 NICHD 4P50HD076188-04 6685 Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer KURITA, TAKESHI NORTHWESTERN UNIVERSITY AT CHICAGO IL $331,241
Pediatric Cancer 2016 NCI 4R01CA114567-10 Targeted therapy in ex vivo medulloblastoma/PNET OLSON, JAMES FRED HUTCHINSON CANCER RESEARCH CENTER WA $227,292
Pediatric Cancer 2016 NCI 4R01CA174794-04 Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation KRULL, KEVIN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $642,665
Pediatric Cancer 2016 NICHD 5R01HD081123-02 Personalized Whole Body Staging for Children with Cancer: A Solution to the Conundrum of Long-Term Side Effects from CT and PET/CT Scans DALDRUP-LINK, HEIKE STANFORD UNIVERSITY CA $487,628
Pediatric Cancer 2016 NCI 1R01CA192176-01A1 Developmental studies to inform clinical stratification and targeting of SHH MB JOYNER, ALEXANDRA SLOAN-KETTERING INST CAN RESEARCH NY $484,999
Pediatric Cancer 2016 NCI 4P01CA101937-13 7522 Genomics of AML Clonality LEY, TIMOTHY WASHINGTON UNIVERSITY MO $331,298
Pediatric Cancer 2016 NCI 4P01CA101937-13 7523 Genomics of AML Relapse DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $333,043
Pediatric Cancer 2016 NCI 4P01CA101937-13 7524 Genomics of Familial MDS/AML GRAUBERT, TIMOTHY WASHINGTON UNIVERSITY MO $338,993
Pediatric Cancer 2016 NCI 4P01CA101937-13 7525 Genomics of Teatment-Related AML LINK, DANIEL WASHINGTON UNIVERSITY MO $336,859
Pediatric Cancer 2016 NCI 4P01CA101937-13 7526 Clinical Database WESTERVELT, PETER WASHINGTON UNIVERSITY MO $268,229
Pediatric Cancer 2016 NCI 4P01CA101937-13 7527 Specimen Acquisition, Genomic, Transcriptomic and Epigenetic Profilling PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $227,227
Pediatric Cancer 2016 NCI 4P01CA101937-13 7528 Sequencing and Integrated Analysis of AML Genomes WILSON, RICHARD WASHINGTON UNIVERSITY MO $902,342
Pediatric Cancer 2016 NCI 4P01CA101937-13 7529 Administration LEY, TIMOTHY WASHINGTON UNIVERSITY MO $150,298
Pediatric Cancer 2016 NCI 4R01CA175759-04 Creating and Validating Child Adverse Event Reporting in Oncology Trials REEVE, BRYCE UNIV OF NORTH CAROLINA CHAPEL HILL NC $1
Pediatric Cancer 2016 NCI 5UM1CA183730-03 Collaborative Human Tissue Network (CHTN) RAMIREZ, NILSA RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $774,914
Pediatric Cancer 2016 NCI 5F30CA183497-03 Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia MCKENNEY, ANNA WEILL MEDICAL COLL OF CORNELL UNIV NY $48,576
Pediatric Cancer 2016 NCI 1R01CA197903-01A1 Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma ZHONG, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $394,607
Pediatric Cancer 2016 NCI 5U01CA183030-03 Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML LIU, YANG CHILDREN'S RESEARCH INSTITUTE DC $472,123
Pediatric Cancer 2016 NIDDK 4K08DK091360-06 Characterization of Genetic Abnormalities in MDS and Their Clinical Impact BEJAR, RAFAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $157,442
Pediatric Cancer 2016 NCI 1U01CA202943-01 Developing a translational pipeline for NF1-mutant malignancies CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $578,917
Pediatric Cancer 2016 NCI 5R01CA133379-08 The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $381,375
Pediatric Cancer 2016 NIMHD 5R01MD007801-03 Reducing racial/ethnic inequities in childhood cancer survivorship MILAM, JOEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,142
Pediatric Cancer 2016 NCI 5R01CA090576-16 Studies of BCR-ABL leukemogenesis in mice VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $274,559
Pediatric Cancer 2016 NCI 4R01CA166749-04 The Role of Growth Factor Receptor Trafficking in Tumorigenesis ZAGE, PETER BAYLOR COLLEGE OF MEDICINE TX $318,913
Pediatric Cancer 2016 NCI 5R03CA195618-02 Biomarkers in pediatric versus adult myelodysplastic syndromes VERNERIS, MICHAEL UNIVERSITY OF MINNESOTA MN $76,000
Pediatric Cancer 2016 NCI 5R01CA175353-03 Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu ROBINS, HARLAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $648,389
Pediatric Cancer 2016 NCI 4R01CA161780-05 Genetic Risk Factors for Ewing's Sarcoma SCHIFFMAN, JOSHUA UNIVERSITY OF UTAH UT $573,919
Pediatric Cancer 2016 NCI 4R01CA177307-04 Targeting the MLL-WDR5 protein-protein interaction WANG, SHAOMENG UNIVERSITY OF MICHIGAN MI $451,476
Pediatric Cancer 2016 NCI 5R01CA195692-02 Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management GUTMANN, DAVID WASHINGTON UNIVERSITY MO $564,104
Pediatric Cancer 2016 NCI 5F31CA196045-02 The role of PRDM16 in Leukemia CORRIGAN, DAVID COLUMBIA UNIVERSITY HEALTH SCIENCES NY $40,602
Pediatric Cancer 2016 NCI 4R01CA175215-04 Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer RADICH, JERALD FRED HUTCHINSON CANCER RESEARCH CENTER WA $585,953
Pediatric Cancer 2016 NCI 4R01CA163870-04 Comb External Beam Radiotherapy with 153Sm-EDTMP to Treat High Risk Osteosarcoma LOEB, DAVID JOHNS HOPKINS UNIVERSITY MD $188,970
Pediatric Cancer 2016 NINDS 5R01NS078092-06 A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets LU, QING CINCINNATI CHILDRENS HOSP MED CTR OH $341,250
Pediatric Cancer 2016 NCI 4R01CA166616-05 Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML SHAH, NEIL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $320,588
Pediatric Cancer 2016 NCI 4R01CA176091-04 Crenolanib and ponatinib for the treatment of FLT3 mutant AML SHAH, NEIL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Pediatric Cancer 2016 NCI 5R01CA172067-05 Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma DUBOIS, STEVEN DANA-FARBER CANCER INST MA $363,426
Pediatric Cancer 2016 NCI 4R01CA101774-14 Mechanisms of Leukemogenesis in Down Syndrome CRISPINO, JOHN NORTHWESTERN UNIVERSITY AT CHICAGO IL $303,965
Pediatric Cancer 2016 NCI 7R01CA194094-02 Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML LI, HONG-YU UNIV OF ARKANSAS FOR MED SCIS AR $370,810
Pediatric Cancer 2016 NCI 1F31CA203252-01 Determining the Role of Tumor-Associated Macrophages in oHSV Antitumor Efficacy in Ewing Sarcoma and Rhabdomyosarcoma DENTON, NICHOLAS RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $34,664
Pediatric Cancer 2016 NCI 4R01CA151535-05 Role of TET proteins in myeloid malignancies RAO, ANJANA LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $370,180
Pediatric Cancer 2016 NCI 1R43CA203172-01 A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia MU, XUEYAN TEAMEDON INTERNATIONAL, LLC MD $278,000
Pediatric Cancer 2016 NCI 1R43CA203166-01 Novel Bone-Targeting Combination Therapy for Osteosarcoma ZINNEN, SHAWN MBC RESEARCH, INC. CO $301,877
Pediatric Cancer 2016 NCI 1R43CA203351-01 Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS MORGAN, LEE DEKK-TEC, INC. LA $90,362
Pediatric Cancer 2016 NCI 5R21CA195689-02 Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes NAORA, HONAMI UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,000
Pediatric Cancer 2016 NCI 1F32CA203049-01 Targeting PRL2 phosphatase in acute myeloid leukemia NABINGER, SARAH INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $61,137
Pediatric Cancer 2016 NCI 1F31CA203053-01 The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis SECHLER, MARYBETH UNIVERSITY OF COLORADO DENVER CO $32,837
Pediatric Cancer 2016 NCI 5U01CA176063-03 ARID5B and disparities of childhood leukemia YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $365,074
Pediatric Cancer 2016 NCI 5R01CA177810-02 Modulation of MicroRNAs with Xenobiotics to Target c-Myc LI, YONG CLEVELAND CLINIC LERNER COM-CWRU OH $368,859
Pediatric Cancer 2016 NICHD 5R00HD070953-05 Risk and Protective Factors for Immune Health in Pediatric Cancer WINTER, MARCIA VIRGINIA COMMONWEALTH UNIVERSITY VA $231,138
Pediatric Cancer 2016 NCI 1F31CA203161-01 Targeting PARP and RAD52 to induce "dual synthetic lethality" in leukemia patients identified by gene expression and mutation profiling SULLIVAN, KATHERINE TEMPLE UNIV OF THE COMMONWEALTH PA $29,195
Pediatric Cancer 2016 NIDDK 1F30DK108532-01 microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome. WEISS, CARY ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $48,576
Pediatric Cancer 2016 NCI 1F30CA203292-01 Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies SWAROOP, ALOK UNIVERSITY OF FLORIDA FL $37,411
Pediatric Cancer 2016 NCATS 1R13CA203289-01 Developing Endpoints to Facilitate Clinical Trials in Rare Diseases PLOTKIN, SCOTT MASSACHUSETTS GENERAL HOSPITAL MA $6,000
Pediatric Cancer 2016 NCI 1R13CA203289-01 Developing Endpoints to Facilitate Clinical Trials in Rare Diseases PLOTKIN, SCOTT MASSACHUSETTS GENERAL HOSPITAL MA $3,993
Pediatric Cancer 2016 NCI 1R01CA197991-01A1 Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia PARDEE, TIMOTHY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $354,563
Pediatric Cancer 2016 NCI 5F30CA192832-02 ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development LANG, YUN LONG UNIV OF NORTH CAROLINA CHAPEL HILL NC $33,814
Pediatric Cancer 2016 NCI 5R01CA132946-09 Pharmacogenomics of Ara-C in AML LAMBA, JATINDER UNIVERSITY OF FLORIDA FL $310,509
Pediatric Cancer 2016 NCI 5R01CA193890-02 HAUSP inhibitors in p53-wild type and p53-mutant tumors GU, WEI COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Pediatric Cancer 2016 NHLBI 5R01HL052725-22 Molecular Pathogenesis of Fanconi Anemia D'ANDREA, ALAN DANA-FARBER CANCER INST MA $400,792
Pediatric Cancer 2016 NCI 4R01CA158350-05 Targeting the aberrant kinome-epigenome in AML GARZON, RAMIRO OHIO STATE UNIVERSITY OH $308,958
Pediatric Cancer 2016 NCI 5R01CA178030-03 Regulation of transcription and tumor suppression by MTG family members HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $364,000
Pediatric Cancer 2016 NCI 5R01CA185402-03 (PQD-5) Patient derived orthotopic xenograft models for drug response prediction LI, XIONAN BAYLOR COLLEGE OF MEDICINE TX $322,828
Pediatric Cancer 2016 NCI 4R01CA154561-06 Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy SEO, YOUNGHO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $350,001
Pediatric Cancer 2016 NCI 5F30CA196244-02 The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors SCOVILLE, STEVEN OHIO STATE UNIVERSITY OH $48,576
Pediatric Cancer 2016 NCI 5R01CA174851-03 A longitudinal assessment of frailty in young adult survivors of childhood cancer NESS, KIRSTEN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $535,247
Pediatric Cancer 2016 NCI 4R01CA166025-04 Molecular Basis of Familial Paraganglioma MAHER, LOUIS MAYO CLINIC ROCHESTER MN $296,933
Pediatric Cancer 2016 NCI 5K08CA174750-03 Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy CAPITINI, CHRISTIAN UNIVERSITY OF WISCONSIN-MADISON WI $178,740
Pediatric Cancer 2016 NCI 5U24CA196173-02 COG Biospecimen Bank RAMIREZ, NILSA RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $2,244,903
Pediatric Cancer 2016 NCI 4R01CA175231-04 Reducing Skin Cancer Risk in Childhood Cancer Survivors GELLER, ALAN HARVARD SCHOOL OF PUBLIC HEALTH MA $638,094
Pediatric Cancer 2016 NCI 5R21CA194217-02 Targeting osteoblasts to inhibit AML HEDIN, KAREN MAYO CLINIC ROCHESTER MN $172,913
Pediatric Cancer 2016 NIAID 5R21AI119894-02 Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis KEE, BARBARA UNIVERSITY OF CHICAGO IL $227,372
Pediatric Cancer 2016 NCI 4U01CA168426-05 Systems Biology of Tumor Progression and Drug Resistance CALIFANO, ANDREA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,238,106
Pediatric Cancer 2016 NCI 5R01CA175761-03 Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis PERKINS, ARCHIBALD UNIVERSITY OF ROCHESTER NY $356,888
Pediatric Cancer 2016 NHLBI 5R01HL114582-03 Role of TRAF6 in Myelodysplastic Syndromes STARCZYNOWSKI, DANIEL CINCINNATI CHILDRENS HOSP MED CTR OH $398,308
Pediatric Cancer 2016 NIEHS 4R01ES022054-05 Study DNA repair in preventing MDS and AML after radiation and benzene exposure HASTY, EDWARD UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $334,415
Pediatric Cancer 2016 NCI 4R01CA168622-04 Cell Fate Control by Integrated E2F, FoxO and PI3K Signaling in Retinoblastoma HALLSTROM, TIMOTHY UNIVERSITY OF MINNESOTA MN $315,400
Pediatric Cancer 2016 NCI 4R01CA159013-05 Online Problem-Solving Skills Training for Mothers of Childhood Cancer Patients SAHLER, OLLE JANE UNIVERSITY OF ROCHESTER NY $752,832
Pediatric Cancer 2016 NIDCR 5R01DE024392-03 Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells VIGNESWARAN, NADARAJAH UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $383,817
Pediatric Cancer 2016 NIGMS 4R01GM101087-05 Dissecting the Signaling Mechanisms of Smoothened OGDEN, STACEY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $336,875
Pediatric Cancer 2016 NCI 5R00CA168996-04 The role of Jmjd1c in normal and leukemic hematopoiesis ZHU, NAN BLOODCENTER OF WISCONSIN, INC. WI $243,927
Pediatric Cancer 2016 NCI 5R21CA194608-02 Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy GARTEL, ANDREI UNIVERSITY OF ILLINOIS AT CHICAGO IL $173,873
Pediatric Cancer 2016 NCI 5R03CA188733-02 Genetic susceptibility to acute lymphocytic and myeloid leukemia HAHN, THERESA ROSWELL PARK CANCER INSTITUTE CORP NY $87,750
Pediatric Cancer 2016 NCI 5R01CA194552-02 RETARGETING AGENTS TO TREAT AML DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $380,068
Pediatric Cancer 2016 NCI 5K08CA194256-02 Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML) GILL, SAAR UNIVERSITY OF PENNSYLVANIA PA $167,832
Pediatric Cancer 2016 NCI 4R01CA169162-05 Targeting non-classical oncogenes as therapy for T-ALL DIACOVO, THOMAS COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Pediatric Cancer 2016 NINDS 5R01NS085336-03 Pediatric low-grade gliomas: biology and molecular targeting. RESNICK, ADAM CHILDREN'S HOSP OF PHILADELPHIA PA $367,500
Pediatric Cancer 2016 NCI 5R01CA173852-03 Role of p21 activated kinase in Leukemogenesis KAPUR, REUBEN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Pediatric Cancer 2016 NCI 5R01CA193776-02 Improving risk allocation and developing novel therapies for children with T-ALL TEACHEY, DAVID CHILDREN'S HOSP OF PHILADELPHIA PA $626,176
Pediatric Cancer 2016 NCI 5R01CA194923-02 Long non-coding RNAs in hematopoiesis and blood malignancy AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $457,533
Pediatric Cancer 2016 NCI 5R01CA098571-12 Molecular Mechanisms of eIF4E mediated transformation BORDEN, KATHERINE UNIVERSITY OF MONTREAL CANADA $227,057
Pediatric Cancer 2016 NCI 4U01CA176287-04 Genetic network analysis of cancer targets WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $308,486
Pediatric Cancer 2016 NCI 5F32CA183527-03 Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers ONDRUS, ALISON STANFORD UNIVERSITY CA $64,146
Pediatric Cancer 2016 NCI 5R01CA185062-03 (PQB3) CD4 T cell response to BCR-ABL-positive Leukemia FARRAR, MICHAEL UNIVERSITY OF MINNESOTA MN $312,341
Pediatric Cancer 2016 NCI 4R01CA154619-05 Anticancer Drug Pharmacology in Very Young Children STEWART, CLINTON ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $433,475
Pediatric Cancer 2016 NCI 4R01CA161202-05 Functional analysis of leukemic CREBBP mutations MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $363,125
Pediatric Cancer 2016 NCI 5R01CA182633-03 Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma ASGHARZADEH, SHAHAB CHILDREN'S HOSPITAL OF LOS ANGELES CA $665,155
Pediatric Cancer 2016 NCI 5R01CA188516-03 Cooperating Pathways in Gliomagenesis BAKER, SUZANNE ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $372,203
Pediatric Cancer 2016 NCI 5R21CA198392-02 A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatric solid tumors OTTO, MARIO UNIVERSITY OF WISCONSIN-MADISON WI $166,388
Pediatric Cancer 2016 NCI 5R01CA190509-02 The function of cyclin C in tumorigenesis SICINSKI, PETER DANA-FARBER CANCER INST MA $453,569
Pediatric Cancer 2016 NCI 5R21CA181875-02 Cdk5 signaling in ICN1-induced T Cell Leukemogenesis HUANG, ALEX CASE WESTERN RESERVE UNIVERSITY OH $172,369
Pediatric Cancer 2016 NCI 4R01CA178765-04 Transcriptional regulatory mechanisms in B cell development and leukemogenesis ROEDER, ROBERT ROCKEFELLER UNIVERSITY NY $565,455
Pediatric Cancer 2016 NCI 4R01CA162665-05 Targeting Leukemia Stem Cells with Dietary Selenium PRABHU, KUMBLE PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $303,222
Pediatric Cancer 2016 NCI 5R01CA169368-04 Therapeutic Exploitation of Mutant BRAF for Astrocytoma HOUGHTON, PETER UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $138,308
Pediatric Cancer 2016 NCI 4R01CA171972-04 Targeted Elimination of Cancer Stem Cells for AML Therapy LIU, YANG CHILDREN'S RESEARCH INSTITUTE DC $463,347
Pediatric Cancer 2016 NCI 4R01CA166327-04 Regulation of Tumor Metabolism by Retinoblastoma Protein CLEM, BRIAN UNIVERSITY OF LOUISVILLE KY $195,750
Pediatric Cancer 2016 NCI 5R01CA185058-03 Impact of low IL-10 levels at birth and leukemia risk WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $624,355
Pediatric Cancer 2016 NINDS 5R01NS088355-02 Targeting BET-bromodomains in neuroblastoma WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $669,055
Pediatric Cancer 2016 NCI 4R01CA172385-04 Validation and Development of WEE1 as a therapeutic target in AML PORTER, CHRISTOPHER UNIVERSITY OF COLORADO DENVER CO $316,213
Pediatric Cancer 2016 NIDDK 5R01DK103961-04 Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes VERMA, AMIT ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $358,005
Pediatric Cancer 2016 NCI 5R01CA192652-02 Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media BULLER, DAVID KLEIN BUENDEL, INC. CO $671,522
Pediatric Cancer 2016 NCI 5R01CA140198-08 Targeting Oncogenic ALK Signaling in Neuroblastoma MOSSE, YAEL CHILDREN'S HOSP OF PHILADELPHIA PA $374,344
Pediatric Cancer 2016 NCI 5R01CA182284-04 Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats COLE, PETER ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $346,525
Pediatric Cancer 2016 NCI 5R01CA183776-04 (PQB-2) "Driver" vs. "passenger" epigenetic events in Ewing sarcoma LESSNICK, STEPHEN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $309,175
1234


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer